New Releases from NCBI BookshelfCarfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal).​Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal).